From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Clinical data
Other names5F-MDMB-2201; 5-Fluoro MDMB-PICA
Legal status
Legal status
CAS Number
PubChem CID
Chemical and physical data
Molar mass376.472 g·mol−1
3D model (JSmol)

5F-MDMB-PICA is a designer drug and synthetic cannabinoid.[1][2] In 2018, it was the fifth-most common synthetic cannabinoid identified in drugs seized by the Drug Enforcement Administration.[3]

5F-MDMB-PICA is a potent agonist of both the CB1 receptor and the CB2 receptor with EC50 values of 0.45 nM and 7.4 nM, respectively.[4]

In the United States, 5F-MDMB-PICA is a Schedule I Controlled Substance.[5] In December of 2019, the UNODC announced scheduling recommendations placing 5F-MDMB-PICA into Schedule II.[6]


  1. ^ Risseeuw, Martijn D.P.; Blanckaert, Peter; Coopman, Vera; Van Quekelberghe, Stijn; Van Calenbergh, Serge; Cordonnier, Jan (2017). "Identification of a new tert -leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA)". Forensic Science International. 273: 45–52. doi:10.1016/j.forsciint.2017.01.023. hdl:1854/LU-8542830. PMID 28214755.
  2. ^ Mogler, Lukas; Franz, Florian; Rentsch, Daniel; Angerer, Verena; Weinfurtner, Georg; Longworth, Mitchell; Banister, Samuel D.; Kassiou, Michael; Moosmann, Bjoern; Auwärter, Volker (2018). "Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples". Drug Testing and Analysis. 10 (1): 196–205. doi:10.1002/dta.2201. PMID 28371476.
  3. ^ "Emerging Threat Report: Annual 2018" (PDF). Special Testing and Research Laboratory, Drug Enforcement Administration.
  4. ^ Banister, Samuel D.; Longworth, Mitchell; Kevin, Richard; Sachdev, Shivani; Santiago, Marina; Stuart, Jordyn; Mack, James B. C.; Glass, Michelle; McGregor, Iain S.; Connor, Mark; Kassiou, Michael (2016). "Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues". ACS Chemical Neuroscience. 7 (9): 1241–1254. doi:10.1021/acschemneuro.6b00137. PMID 27421060.
  5. ^ "Schedules of Controlled Substances: Temporary Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 into Schedule I". Federal Register. 2019-04-16.
  6. ^ "December 2019 – WHO: World Health Organization recommends 12 NPS for scheduling".